How I treat anemia in pregnancy: Iron, cobalamin, and folate

Blood

Volumn 129, Issue 8, 2017, Pages 940-949

  Achebe, Maureen M ^a,b   Gafter Gvili, Anat ^c,d,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Institute of Hematology   (United States)

^d RABIN MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; FERRITIN; FOLIC ACID; HEMOGLOBIN; HEPCIDIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR; ANTIANEMIC AGENT; CYANOCOBALAMIN; FERRYL IRON; VITAMIN B COMPLEX;

ADULT; ARTICLE; CASE REPORT; CONSTIPATION; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC TEST; DYSPNEA; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FOLIC ACID DEFICIENCY; GASTRIC BAND; HEART PALPITATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILEITIS; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; MEAN CORPUSCULAR VOLUME; MEDICAL HISTORY; MENORRHAGIA; NAUSEA; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRIORITY JOURNAL; RED BLOOD CELL DISTRIBUTION WIDTH; RESTLESSNESS; ROUX-EN-Y GASTRIC BYPASS; ANEMIA; ANEMIA, IRON-DEFICIENCY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VITAMIN B 12 DEFICIENCY;

ADULT; ANEMIA; ANEMIA, IRON-DEFICIENCY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HEMATINICS; HUMANS; IRON; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; VITAMIN B COMPLEX;

EID: 85015248244     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-08-672246     Document Type: Article

References (115)

1. World Health Organization. Iron Deficiency Anaemia: Assessment, Prevention and Control: A Guide for Programme Managers. Geneva, Switzerland: World Health Organization; 2001.
2. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep. 1998;47(RR-3):1-29.
3. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, Switzerland: World Health Organization; 2011.
4. Milman N, Byg KE, Agger AO. Hemoglobin and erythrocyte indices during normal pregnancy and postpartum in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand. 2000;79(2):89-98.
5. Lee AI, Okam MM. Anemia in pregnancy. Hematol Oncol Clin North Am. 2011;25(2): 241-259.
6. Stevens GA, Finucane MM, De-Regil LM, et al; Nutrition Impact Model Study Group (Anaemia). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995- 2011: A systematic analysis of populationrepresentative data. Lancet Glob Health. 2013; 1(1):e16-e25.
7. Ren A, Wang J, Ye RW, Li S, Liu JM, Li Z. Low first-trimester hemoglobin and low birth weight, preterm birth and small for gestational age newborns. Int J Gynaecol Obstet. 2007;98(2): 124-128.
8. de Śa SA, Willner E, Duraes Pereira TA, de Souza VR, Teles Boaventura G, Blondet de Azeredo V. Anemia in pregnancy: impact on weight and in the development of anemia in newborn. Nutr Hosp. 2015;32(5):2071-2079.
9. Geng F, Mai X, Zhan J, et al. Impact of fetalneonatal iron deficiency on recognition memory at 2 months of age. J Pediatr. 2015;167(6): 1226-1232.
10. Congdon EL, Westerlund A, Algarin CR, et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr. 2012;160(6):1027-1033.
11. De-Regil LM, Ferńandez-Gaxiola AC, Dowswell T, Pena-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010;(10):CD007950.
12. van Uitert EM, Steegers-Theunissen RP. Influence of maternal folate status on human fetal growth parameters. Mol Nutr Food Res. 2013;57(4):582-595.
13. Rush EC, Katre P, Yajnik CS. Vitamin B12: one carbon metabolism, fetal growth and programming for chronic disease. Eur J Clin Nutr. 2014;68(1):2-7.
14. US Preventive Services Task Force. Routine iron supplementation during pregnancy. Review article. JAMA. 1993;270(23):2848-2854.
15. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Arch Gynecol Obstet. 2010;282(5):577-580.
16. Milman N, Agger AO, Nielsen OJ. Iron status markers and serum erythropoietin in 120 mothers and newborn infants. Effect of iron supplementation in normal pregnancy. Acta Obstet Gynecol Scand. 1994;73(3):200-204.
17. Arnold DL, Williams MA, Miller RS, Qiu C, Sorensen TK. Iron deficiency anemia, cigarette smoking and risk of abruptio placentae. J Obstet Gynaecol Res. 2009;35(3):446-452.
18. Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011; (10):CD003094.
19. Scholl TO. Maternal iron status: relation to fetal growth, length of gestation, and iron endowment of the neonate. Nutr Rev. 2011;69(suppl 1): S23-S29.
20. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr. 2000; 72(suppl 1):257S-264S.
21. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C; British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156(5):588-600.
22. Williams MD, Wheby MS. Anemia in pregnancy. Med Clin North Am. 1992;76(3):631-647.
23. Milman N, Agger AO, Nielsen OJ. Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women. Dan Med Bull. 1991;38(6):471-476.
24. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998; 44(1):45-51.
25. Romslo I, Haram K, Sagen N, Augensen K. Iron requirement in normal pregnancy as assessed by serum ferritin, serum transferrin saturation and erythrocyte protoporphyrin determinations. Br J Obstet Gynaecol. 1983;90(2):101-107.
26. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of irondeficiency anemia: An overview. J Gen Intern Med. 1992;7(2):145-153.
27. van den Broek NR, Letsky EA, White SA, Shenkin A. Iron status in pregnant women: which measurements are valid? Br J Haematol. 1998; 103(3):817-824.
28. Tietz NW, Rinker AD, Morrison SR. When is a serum iron really a serum iron? The status of serum iron measurements. Clin Chem. 1994; 40(4):546-551.
29. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-38.
30. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843.
31. Punnonen K, Irjala K, Rajam aki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997; 89(3):1052-1057.
32. Infusino I, Braga F, Dolci A, Panteghini M. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. Am J Clin Pathol. 2012;138(5):642-649.
33. van Santen S, Kroot JJ, Zijderveld G, Wiegerinck ET, Spaanderman ME, Swinkels DW. The iron regulatory hormone hepcidin is decreased in pregnancy: A prospective longitudinal study. Clin Chem Lab Med. 2013;51(7):1395-1401.
34. Koenig MD, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E. Hepcidin and iron homeostasis during pregnancy. Nutrients. 2014; 6(8):3062-3083.
35. Bah A, Wegmuller R, Cerami C, et al. A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron. BMC Pregnancy Childbirth. 2016;16(1):157.
36. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: A systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383.
37. Beard JL. Effectiveness and strategies of iron supplementation during pregnancy. Am J Clin Nutr. 2000;71(suppl 5):1288S-12945.
38. Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM. Efficacy and tolerability of lowdose iron supplements during pregnancy: A randomized controlled trial. Am J Clin Nutr. 2003;78(1):145-153.
39. Milman N, Paszkowski T, Cetin I, Castelo- Branco C. Supplementation during pregnancy: beliefs and science. Gynecol Endocrinol. 2016; 32(7):509-516.
40. Cook JD, Reddy MB. Efficacy of weekly compared with daily iron supplementation. Am J Clin Nutr. 1995;62(1):117-120.
41. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015; 126(17):1981-1989.
42. Okam MM, Koch TA, Tran MH. Iron deficiency anemia treatment response to oral iron therapy: A pooled analysis of five randomized controlled trials. Haematologica. 2016;101(1):e6-e7.
43. Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail. 2012;14(4):423-429.
44. Avni T, Bieber A, Steinmetz T, Leibovici L, Gafter-Gvili A. Treatment of anemia in inflammatory bowel disease-systematic review and meta-analysis. PLoS One. 2013;8(12): e75540.
45. Shepshelovich D, Rozen-Zvi B, Avni T, Gafter U, Gafter-Gvili A. Intravenous versus oral iron supplementation for the treatment of anemia in CKD: An updated systematic review and metaanalysis. Am J Kidney Dis. 2016;68(5):677-690.
46. Gafter-Gvili A, Rozen-Zvi B, Vidal L, et al. Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials. Acta Oncol. 2013; 52(1):18-29.
47. Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: A randomized trial. J Matern Fetal Neonatal Med. 2013;26(7):654-659.
48. Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: A randomized clinical trial. J Obstet Gynaecol Res. 2013;39(2): 504-510.
49. Neeru S, Nair NS, Rai L. Iron sucrose versus oral iron therapy in pregnancy anemia. Indian J Community Med. 2012;37(4):214-218.
50. Bencaiova G, von Mandach U, Zimmermann R. Iron prophylaxis in pregnancy: intravenous route versus oral route. Eur J Obstet Gynecol Reprod Biol. 2009;144(2):135-139.
51. Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: A randomized trial. Obstet Gynecol. 2005;106(6):1335-1340.
52. Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol. 2002;186(3):518-522.
53. Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J; FER-ASAP Investigators. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: An international, open-label, randomized controlled trial (FER-ASAP) [published online ahead of print 8 June 2016]. J Perinat Med. doi:10.1515/jpm-2016-0050.
54. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet. 2008;101(1):67-73.
55. New Recommendations to Manage Risk of Allergic Reactions With Intravenous Iron- Containing Medicines. Vol. EMA/377372/2013. London, United Kingdom: European Medicine Agency; 2013.
56. Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol. 2004;15(suppl 2):S93-S98.
57. Auerbach M, Coyne D, Ballard H. Intravenous iron: from anathema to standard of care. Am J Hematol. 2008;83(7):580-588.
58. Okam MM, Mandell E, Hevelone N, Wentz R, Ross A, Abel GA. Comparative rates of adverse events with different formulations of intravenous iron. Am J Hematol. 2012;87(11):E123-E124.
59. Bircher AJ, Auerbach M. Hypersensitivity from intravenous iron products. Immunol Allergy Clin North Am. 2014;34(3):707-723.
60. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet. 2007;369(9572):1502-1504.
61. Aronoff GR. Safety of intravenous iron in clinical practice: implications for anemia management protocols. J Am Soc Nephrol. 2004;15(suppl 2): S99-S106.
62. Auerbach M, Chaudhry M, Goldman H, Ballard H. Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: A double blind randomized trial. J Lab Clin Med. 1998; 131(3):257-260.
63. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90(1): 12-23.
64. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlḿen J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant. 2006;21(2):378-382.
65. McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran-a comparison of two products. Am J Nephrol. 2000;20(6):455-462.
66. Wong L, Smith S, Gilstrop M, et al. Safety and efficacy of rapid (1, 000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol. 2016;91(6):590-593.
67. Ayub R, Tariq N, Adil MM, Iqbal M, Junaid A, Jaferry T. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy. J Coll Physicians Surg Pak. 2008; 18(7):424-427.
68. Myers B, Myers O, Moore J. Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy. Obstet Med. 2012;5(3):105-107.
69. Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth. 2014;14: 115.
70. Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. Intravenous iron treatment in pregnancy: comparison of highdose ferric carboxymaltose vs. iron sucrose. J Perinat Med. 2012;40(5):469-474.
71. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci. 2000;900:125-136.
72. Açkurt F, Wetherilt H, Loker M, Hacibekirǒglu M. Biochemical assessment of nutritional status in pre- And post-natal Turkish women and outcome of pregnancy. Eur J Clin Nutr. 1995;49(8): 613-622.
73. Grieger JA, Clifton VL. A review of the impact of dietary intakes in human pregnancy on infant birthweight. Nutrients. 2014;7(1):153-178.
74. Frenkel EP, Yardley DA. Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology. Hematol Oncol Clin North Am. 2000;14(5):1079-1100.
75. Maggard MA, Yermilov I, Li Z, et al. Pregnancy and fertility following bariatric surgery: A systematic review. JAMA. 2008;300(19): 2286-2296.
76. Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition. 2009;25(11-12):1150-1156.
77. Karaoglu L, Pehlivan E, Egri M, et al. The prevalence of nutritional anemia in pregnancy in an east Anatolian province, Turkey. BMC Public Health. 2010;10:329.
78. Matchar DB, McCrory DC, Millington DS, Feussner JR. Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am J Med Sci. 1994;308(5):276-283.
79. Pardo J, Peled Y, Bar J, et al. Evaluation of low serum vitamin B(12) in the non-anaemic pregnant patient. Hum Reprod. 2000;15(1): 224-226.
80. Metz J, McGrath K, Bennett M, Hyland K, Bottiglieri T. Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal serum vitamin B12 levels. Am J Hematol. 1995; 48(4):251-255.
81. Ball EW, Giles C. Folic acid and vitamin B12 levels in pregnancy and their relation to megaloblastic anaemia. J Clin Pathol. 1964;17: 165-174.
82. Pardo J, Gindes L, Orvieto R. Cobalamin (vitamin B12) metabolism during pregnancy. Int J Gynaecol Obstet. 2004;84(1):77-78.
83. Morkbak AL, Hvas AM, Milman N, Nexo E. Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. Haematologica. 2007;92(12): 1711-1712.
84. Galloway M, Rushworth L. Red cell or serum folate? Results from the National Pathology Alliance benchmarking review. J Clin Pathol. 2003;56(12):924-926.
85. De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007; 357(2):135-142.
86. Khoshnood B, Loane M, de Walle H, et al. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ. 2015; 351:h5949.
87. Green R, Miller JW. Folate deficiency beyond megaloblastic anemia: hyperhomocysteinemia and other manifestations of dysfunctional folate status. Semin Hematol. 1999;36(1):47-64.
88. U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(9):626-631.
89. Mead NC, Sakkatos P, Sakellaropoulos GC, Adonakis GL, Alexandrides TK, Kalfarentzos F. Pregnancy outcomes and nutritional indices after 3 types of bariatric surgery performed at a single institution. Surg Obes Relat Dis. 2014;10(6): 1166-1173.
90. World Health Organization and Food and Agriculture Organization of the United Nations. Vitamin and mineral requirements in human nutrition. Geneva, Switzerland: World Health Organization; 2004:341.
91. National Institutes of Health Office of Dietary Supplements. Vitamin B12 Fact Sheet for Consumers. Washington, DC: US Department of Health and Human Services; 2016.
92. Bicakci Z. Growth retardation, general hypotonia, and loss of acquired neuromotor skills in the infants of mothers with cobalamin deficiency and the possible role of succinyl-CoA and glycine in the pathogenesis. Medicine (Baltimore). 2015; 94(9):e584.
93. Torsvik I, Ueland PM, Markestad T, Bjørke-Monsen AL. Cobalamin supplementation improves motor development and regurgitations in infants: results from a randomized intervention study. Am J Clin Nutr. 2013;98(5):1233-1240.
94. Sharabi A, Cohen E, Sulkes J, Garty M. Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route. Br J Clin Pharmacol. 2003;56(6):635-638.
95. Holtz TH, Kachur SP, Roberts JM, et al. Use of antenatal care services and intermittent preventive treatment for malaria among pregnant women in Blantyre District, Malawi. Trop Med Int Health. 2004;9(1):77-82.
96. Helitzer-Allen DL, McFarland DA, Wirima JJ, Macheso AP. Malaria chemoprophylaxis compliance in pregnant women: A costeffectiveness analysis of alternative interventions. Soc Sci Med. 1993;36(4):403-407.
97. Meńendez C, Bardají A, Sigauque B, et al. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS One. 2010; 5(2):e9438.
98. World Health Organization; Global Malaria Program. Updated WHO Policy Recommendation (October 2012): Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulfadoxine-Pyrimethamine (IPTp-SP). Geneva, Switzerland: World Health Organization; 2012.
99. Greenwood BM. The epidemiology of malaria. Ann Trop Med Parasitol. 1997;91(7):763-769.
100. Menendez C, Fleming AF, Alonso PL. Malariarelated anaemia. Parasitol Today. 2000;16(11): 469-476.
101. Boele van Hensbroek M, Calis JC, Phiri KS, et al. Pathophysiological mechanisms of severe anaemia in Malawian children. PLoS One. 2010; 5(9):e12589.
102. Clark MA, Goheen MM, Fulford A, et al. Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum. Nat Commun. 2014;5:4446.
103. Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. J Infect Dis. 2008; 198(2):163-166.
104. Senga EL, Harper G, Koshy G, Kazembe PN, Brabin BJ. Reduced risk for placental malaria in iron deficient women. Malar J. 2011;10:47.
105. Neuberger A, Okebe J, Yahav D, Paul M. Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst Rev. 2016;2: CD006589.
106. Cross JH, Bradbury RS, Fulford AJ, et al. Oral iron acutely elevates bacterial growth in human serum. Sci Rep. 2015;5:16670.
107. Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015(7):CD004736.
108. Akinola OI, Fabamwo AO, Tayo AO, Rabiu KA, Oshodi YA, Onyekwere CA. Evaluation of blood reservation and use for caesarean sections in a tertiary maternity unit in south western Nigeria. BMC Pregnancy Childbirth. 2010;10:57.
109. Pitman JP, Wilkinson R, Liu Y, et al. Blood component use in a sub-Saharan African country: results of a 4-year evaluation of diagnoses associated with transfusion orders in Namibia. Transfus Med Rev. 2015;29(1):45-51.
110. Bugge HF, Karlsen NC, Oydna E, et al. A study of blood transfusion services at a district hospital in Malawi. Vox Sang. 2013;104(1):37-45.
111. Sentilhes L, Vayssìere C, Deneux-Tharaux C, et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016;198:12-21.
112. Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016; 316(19):2025-2035.
113. Dhanani JV, Ganguly BP, Chauhan LN. Comparison of efficacy and safety of two parenteral iron preparations in pregnant women. J Pharmacol Pharmacother. 2012;3(4):314-319.
114. Pels A, Ganzevoort W. Safety and efficacy of ferric carboxymaltose in anemic pregnant women: A retrospective case control study. Obstet Gynecol Int. 2015;2015:728952.
115. Schneider J, Krafft A, Manconi M, et al. Openlabel study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome. Sleep Med. 2015;16(11):1342-1347.